Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Julphar
Chinese Patent Office
Moodys
Covington
Healthtrust
Chubb
Cantor Fitzgerald

Generated: May 25, 2018

DrugPatentWatch Database Preview

Dexcel Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for DEXCEL PHARMA, and when can generic versions of DEXCEL PHARMA drugs launch?

DEXCEL PHARMA has six approved drugs.

There is one US patent protecting DEXCEL PHARMA drugs.

There are nine patent family members on DEXCEL PHARMA drugs in eight countries and twelve supplementary protection certificates in five countries.

Summary for Dexcel Pharma
International Patents:9
US Patents:1
Tradenames:5
Ingredients:5
NDAs:6
Patent Litigation for Dexcel Pharma: See patent lawsuits for Dexcel Pharma

Drugs and US Patents for Dexcel Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dexcel Pharma OMEPRAZOLE omeprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 209400-001 Jul 5, 2017 OTC Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Dexcel Pharma LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 202167-002 Sep 4, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Dexcel Pharma OMEPRAZOLE omeprazole TABLET, DELAYED RELEASE;ORAL 022032-001 Dec 4, 2007 OTC Yes Yes 9,023,391 ➤ Try a Free Trial Y ➤ Try a Free Trial
Dexcel Pharma LANSOPRAZOLE lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 208025-001 Jun 7, 2016 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Dexcel Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 5,002,769 ➤ Try a Free Trial
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 5,023,082 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DEXCEL PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Non-Orange Book US Patents for Dexcel Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,255,878 Stable benzimidazole formulation ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Dexcel Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021 Belgium ➤ Try a Free Trial PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
00C/032 Belgium ➤ Try a Free Trial PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
C0021 Belgium ➤ Try a Free Trial PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
14/008 Ireland ➤ Try a Free Trial PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cerilliant
AstraZeneca
Merck
US Department of Justice
Colorcon
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.